The world prevalence, associated risk factors and mortality of hepatitis C virus infection in hemodialysis patients: a meta-analysis.

ABSTRACT:

Background

The worldwide burden of HCV infection among hemodialysis patients has not been systematically examined.

Methods

A systematic literature search was conducted in MEDLINE and Scopus to determine the worldwide prevalence of HCV infection, risk factors, and clinical outcomes among hemodialysis patients. Random-effect models and meta-regressions were used to generate pooled estimates and assess heterogeneity.

Results

Four hundred and seven studies with 1,302,167 participants were analyzed. The pooled prevalence of HCV infection was 21%. The highest prevalence was observed in Africa (28%) and low-income countries (48.5%). A significant prevalence decline was observed following the publication year and was also inversely related to GDP and total population of each

SUBMITTER: Greeviroj P 

PROVIDER: S-EPMC9666992 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature